Published on 6 May 2024 on Investing.com
ADC Therapeutics Jumps on Earnings Beat
Start tracking your investments with Statfolio
Key Insights The projected fair value for ADC Therapeutics is US$1.49 based on 2 Stage Free Cash...
ADC Therapeutics SA (NYSE:ADCT) is set to release its Q3 2024 earnings on Nov 7, 2024. The consen...
Key Insights Using the 2 Stage Free Cash Flow to Equity, ADC Therapeutics fair value estimate is ...
On May 7, 2024, Ameet Mallik, Chief Executive Officer of ADC Therapeutics SA (NYSE:ADCT), sold 29...
Last week, you might have seen that ADC Therapeutics SA (NYSE:ADCT) released its quarterly result...
ADC Therapeutics SA (NYSE:ADCT) Q1 2024 Earnings Call Transcript May 6, 2024 ADC Therapeutics SA ...
ADC Therapeutics SA (ADCT) came out with a quarterly loss of $0.56 per share in line with the Zac...
ADC Therapeutics SA (NYSE:ADCT) reported promising initial results from a Phase 2 clinical trial ...
There's been a notable change in appetite for ADC Therapeutics SA (NYSE:ADCT) shares in the week ...